KERALAYURPharmaceuticals
Kerala Ayurveda Ltd — Cash Flow Statement
₹157.75
-8.80%
Kerala Ayurveda Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.50 Cr | -2.05 Cr | 3.68 Cr | -3.35 Cr | — |
| Capital Expenditure | -13.33 Cr | -1.09 Cr | -6.18 Cr | -2.85 Cr | — |
| End Cash Position | 3.39 Cr | 22.81 Cr | 4.38 Cr | 2.87 Cr | — |
| Beginning Cash Position | 22.81 Cr | 4.39 Cr | 2.87 Cr | 18.56 Cr | — |
| Changes In Cash | -19.42 Cr | 18.42 Cr | 1.50 Cr | -15.69 Cr | — |
| Financing Cash Flow | -9.48 Cr | 19.83 Cr | -1.14 Cr | -13.27 Cr | — |
| Net Other Financing Charges | 2.91 Cr | -0.27 Cr | 1.00 | 1.00 | — |
| Interest Paid Cff | -4.09 Cr | -6.04 Cr | -4.82 Cr | -6.52 Cr | — |
| Net Issuance Payments Of Debt | -8.31 Cr | -2.01 Cr | 3.69 Cr | -6.75 Cr | — |
| Net Long Term Debt Issuance | -8.31 Cr | -2.01 Cr | 13.21 Cr | -21.30 Cr | — |
| Investing Cash Flow | -14.77 Cr | -0.45 Cr | -7.22 Cr | -1.91 Cr | — |
| Interest Received Cfi | -0.03 Cr | 0.14 Cr | 0.08 Cr | 0.26 Cr | — |
| Net PPE Purchase And Sale | -13.32 Cr | -1.09 Cr | -6.11 Cr | -2.85 Cr | — |
| Sale Of PPE | 87000.00 | 16000.00 | 0.07 Cr | 0.00 | — |
| Purchase Of PPE | -13.33 Cr | -1.09 Cr | -6.18 Cr | -2.85 Cr | — |
| Operating Cash Flow | 4.83 Cr | -0.96 Cr | 9.86 Cr | -0.50 Cr | — |
| Taxes Refund Paid | -2.05 Cr | -1.04 Cr | -0.37 Cr | 0.00 | — |
| Interest Received Cfo | 0.03 Cr | 1.64 Cr | 1.63 Cr | 1.52 Cr | — |
| Change In Working Capital | 4.60 Cr | -9.61 Cr | 4.61 Cr | -11.12 Cr | — |
| Change In Other Current Liabilities | 10.16 Cr | 0.10 Cr | 1.57 Cr | -2.09 Cr | — |
| Change In Other Current Assets | -1.09 Cr | -1.10 Cr | 2.95 Cr | -6.84 Cr | — |
| Change In Payable | -1.05 Cr | -1.33 Cr | -0.13 Cr | 1.77 Cr | — |
| Change In Inventory | -0.69 Cr | -3.01 Cr | -0.52 Cr | -0.97 Cr | — |
| Change In Receivables | -2.09 Cr | -4.74 Cr | -0.05 Cr | -3.15 Cr | — |
| Other Non Cash Items | 4.09 Cr | 5.89 Cr | -0.08 Cr | -0.26 Cr | — |
| Stock Based Compensation | 6.23 Cr | — | — | — | — |
| Provisionand Write Offof Assets | 0.21 Cr | 0.43 Cr | — | — | — |
| Depreciation And Amortization | 4.97 Cr | 2.14 Cr | 1.11 Cr | 1.20 Cr | — |
| Depreciation | 4.97 Cr | 2.14 Cr | 1.11 Cr | 1.18 Cr | — |
| Pension And Employee Benefit Expense | 0.83 Cr | 0.74 Cr | — | — | — |
| Gain Loss On Investment Securities | 68000.00 | -0.01 Cr | 1.63 Cr | 1.52 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -1.86 Cr | -0.14 Cr | — | — | — |
| Net Income From Continuing Operations | -12.24 Cr | 0.66 Cr | 4.26 Cr | 9.32 Cr | — |
| Issuance Of Debt | — | 9.00 Cr | 13.21 Cr | — | 13.64 Cr |
| Issuance Of Capital Stock | — | 28.15 Cr | 0.00 | — | — |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | -1.00 | -1.00 | 1000.00 |
| Net Common Stock Issuance | — | 28.15 Cr | 0.00 | — | — |
| Common Stock Issuance | — | 28.15 Cr | 0.00 | — | — |
| Net Short Term Debt Issuance | — | -15.05 Cr | -9.52 Cr | 14.54 Cr | -1.12 Cr |
| Long Term Debt Issuance | — | 9.00 Cr | 13.21 Cr | — | 13.64 Cr |
| Net Other Investing Changes | — | -1000.00 | — | 1.00 | — |
| Interest Paid Cfo | — | -1.67 Cr | -1.26 Cr | -1.18 Cr | -1.10 Cr |
| Gain Loss On Sale Of PPE | — | -81000.00 | -0.05 Cr | -10000.00 | 0.00 |
| Amortization Cash Flow | — | — | 72000.00 | 0.02 Cr | — |
| Repayment Of Debt | — | — | — | -21.30 Cr | -1.12 Cr |
| Long Term Debt Payments | — | — | — | -21.30 Cr | -1.12 Cr |
| Dividends Received Cfi | — | — | — | 0.00 | 0.00 |
| Net Investment Purchase And Sale | — | — | — | — | 0.10 Cr |
| Sale Of Investment | — | — | — | — | 0.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kerala Ayurveda Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.